Home/Filings/4/0001127602-18-025355
4//SEC Filing

MIDDLEKAUFF W BRADFORD 4

Accession 0001127602-18-025355

CIK 0001472091other

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 7:40 AM ET

Size

5.4 KB

Accession

0001127602-18-025355

Insider Transaction Report

Form 4
Period: 2018-08-14
MIDDLEKAUFF W BRADFORD
Senior VP, GC and Secretary
Transactions
  • Award

    Restricted Stock Units

    2018-08-14+49,76649,766 total
    Common Stock (49,766 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
  • [F2]These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
  • [F3]Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.

Issuer

Edge Therapeutics, Inc.

CIK 0001472091

Entity typeother

Related Parties

1
  • filerCIK 0001214501

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 7:40 AM ET
Size
5.4 KB